跳至主要内容
临床试验/DRKS00031999
DRKS00031999已完成Unknown

Application of saliva markers for the in vivo testing of dosage forms

Institut für Pharmazie - Biopharmazie & Pharmazeutische Technologie0 个研究点目标入组 12 人开始时间: 2023年8月28日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • Ethnic origin: Caucasian
  • -BMI: > 18 kg/m² and < 30 kg/m²
  • -Minimum weight: 50 kg
  • -Good health, judged by the investigator not to deviate from the norm in clinical terms
  • -Presentation of written informed consent

排除标准

  • - Disorders/diseases affecting the swallowing process (e.g. severe dysphagia with regard to food and/or solid oral dosage forms).
  • - claustrophobia
  • - Gastrointestinal disease and/or pathological changes that may interfere with gastric emptying.
  • - Known or suspected stenosis, fistulae or mechanical obstruction within the gastrointestinal tract.
  • - surgical procedures on the gastrointestinal tract within the last 12 months
  • - inflammatory bowel disease (Crohn's disease, ulcerative colitis or diverticulitis)
  • - implanted or portable electromechanical medical devices such as a pacemaker, defibrillator or infusion pump
  • - Known allergies or intolerances to the ingredients of the standard meal
  • - Individuals who are unable to consume an appropriately sized portion of a meal in a given amount of time
  • - Alcohol or drug addiction
  • - Smokers with a cigarette consumption of more than 10 cigarettes per day
  • - Heavy tea or coffee drinkers (more than 1 litre per day)
  • - Eating disorders such as anorexia, bulimia
  • - Positive pregnancy test or gravidity
  • - People who are known to be unwilling or unable to follow instructions reliably
  • - Individuals who are unable to understand written and verbal instructions and warnings regarding the study risks they face
  • - less than 14 days after acute illness
  • - systemic use of medications, especially those that affect gastrointestinal function
  • - known allergy or hypersensitivity to caffeine or foods containing caffeine
  • - Intolerance to lactose

研究者

发起方
Institut für Pharmazie - Biopharmazie & Pharmazeutische Technologie

相似试验